One of the particular areas of interest in modern health care is nanotechnology. Nanotechnology is technology that enables the detection of small particles in bodily fluids, for instance the concentration of natrium or kalium in urine. This technology can be transferred to small microchips (Lab-on-a-chip) which, in theory, can be used at the point of care (at the bedside of the patient) or even in the home situation, by the patient him or herself.

This study focuses on a lab on a chip for the detection of kidney failure.

The first objective of this project is to determine the most successful market for a device that measures indicators of kidney failure. Possible implementation scenarios include the use of the chip for the detection of kidney disease in diabetic patients, either by the patient or in the general practitioners office and/or the use of the lab-on-a-chip in the hospital to measure kidney failure at the point of care instead of in the laboratory. The second objective of the project is, given the most beneficial implementation scenario, to determine device specifications, estimate the impact of a device on the effectiveness and efficiency of care.

The funding organization for this project is the province of Overijssel ( Nirion website).